Hcv combination therapy

Details Hcv combination therapy Hcv combination therapy

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61K 38/02 (2006.01) A61K 38/04 (2006.01) A61K 38/10 (2006.01) A61K 38/21 (2006.01) A61P 1/16 (2006.01)

Patent

CA 2511562

A peptide which has at least 80% identity to a fragment of Domain A or B of the Hepreceptor of ezrin, is used with an interferon as a combined preparation for simultaneous, separate or sequential use in the treatment of viral hepatitis.

L'invention concerne un peptide présentant au moins une similitude s'élevant à 80 % avec un fragment du domaine A ou B du récepteur HEP de l'ezrine, qui est utilisé avec un interféron en tant que préparation combinée en vue d'une utilisation simultanée, séparée ou séquentielle dans le traitement de l'hépatite virale.

Affiliated with

Also associated with

Rating

Hcv combination therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hcv combination therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv combination therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1831802